Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-03 9:30 pm Sale |
2025-03-03 | 13D | BeiGene, Ltd. ONC |
HHLR Advisors, Ltd. | 92,805,741 6.700% |
-32,240,000 (-25.78%) |
Filing History |
| 2024-12-10 9:30 pm Sale |
2024-12-09 | 13D | BeiGene, Ltd. ONC |
Baker Bros. Advisors LP | 125,276,610 13.000% |
-13,401,427 (-9.66%) |
Filing History |
| 2024-12-04 4:05 pm Sale |
2024-12-02 | 13D | BeiGene, Ltd. ONC |
HHLR Advisors, Ltd. | 125,045,741 9.000% |
-21,997,317 (-14.96%) |
Filing History |
| 2024-10-31 6:29 pm Unchanged |
2024-10-31 | 13D | Leap Therapeutics, Inc. LPTX |
BeiGene Ltd. BGNE |
1,215,306 3.170% |
0 (Unchanged) |
Filing History |
| 2024-10-31 5:40 pm Purchase |
2024-10-31 | 13D | Leap Therapeutics, Inc. LPTX |
BeiGene Ltd. BGNE |
1,215,306 0.000% |
1,215,306 (New Position) |
Filing History |
| 2024-02-09 6:03 pm Sale |
2024-02-07 | 13G | BeiGene, Ltd. ONC |
Capital International Investors | 103,421,157 7.600% |
-6,794,013 (-6.16%) |
Filing History |
| 2024-02-05 4:12 pm Purchase |
2023-12-31 | 13G | BeiGene, Ltd. ONC |
OYLER JOHN | 71,464,808 5.200% |
1,438,411 (+2.05%) |
Filing History |
| 2023-11-14 5:18 pm Sale |
2023-11-14 | 13D | BeiGene, Ltd. ONC |
Baker Bros. Advisors LP | 138,678,037 13.000% |
-14,300,000 (-9.35%) |
Filing History |
| 2023-05-05 4:33 pm Sale |
2023-05-03 | 13D | BeiGene, Ltd. ONC |
Baker Bros. Advisors LP | 152,978,037 13.000% |
-1,337,453 (-0.87%) |
Filing History |
| 2023-02-14 4:14 pm Purchase |
2023-02-14 | 13D | BeiGene, Ltd. ONC |
HHLR Advisors, Ltd. | 147,043,058 10.900% |
7,800 (+0.01%) |
Filing History |
| 2023-02-13 3:54 pm Purchase |
2023-02-14 | 13G | BeiGene, Ltd. ONC |
Capital International Investors | 110,215,170 8.200% |
6,178,993 (+5.94%) |
Filing History |
| 2023-02-10 4:53 pm Sale |
2023-02-10 | 13G | BeiGene, Ltd. ONC |
Invesco Ltd. IVZ |
35,678,240 2.600% |
-3,350,581 (-8.58%) |
Filing History |
| 2023-02-10 4:05 pm Purchase |
2022-12-31 | 13G | BeiGene, Ltd. ONC |
OYLER JOHN | 70,026,397 5.100% |
467,792 (+0.67%) |
Filing History |
| 2022-08-16 4:15 pm Unchanged |
2022-08-16 | 13D | BeiGene, Ltd. ONC |
HHLR Advisors, Ltd. | 147,035,258 10.900% |
0 (Unchanged) |
Filing History |
| 2022-02-14 08:24 am Sale |
2021-12-31 | 13G | BeiGene, Ltd. ONC |
OYLER JOHN | 69,558,605 5.100% |
-2,925,663 (-4.04%) |
Filing History |
| 2022-02-11 5:28 pm Purchase |
2022-02-11 | 13G | BeiGene, Ltd. ONC |
Invesco Ltd. IVZ |
39,028,821 5.600% |
39,028,821 (New Position) |
Filing History |
| 2022-02-11 4:31 pm Sale |
2021-12-31 | 13G | BeiGene, Ltd. ONC |
BeiGene Ltd. BGNE |
69,558,605 5.100% |
-7,218,182 (-9.40%) |
Filing History |
| 2022-02-11 11:19 am Purchase |
2022-02-14 | 13G | BeiGene, Ltd. ONC |
Capital International Investors | 104,036,177 7.800% |
14,141,554 (+15.73%) |
Filing History |
| 2022-02-09 09:09 am Sale |
2022-02-08 | 13G | BeiGene, Ltd. ONC |
FMR CORP | 47,129,292 3.541% |
-15,084,723 (-24.25%) |
Filing History |
| 2021-09-28 6:58 pm Purchase |
2021-09-24 | 13D | Leap Therapeutics, Inc. LPTX |
BeiGene Ltd. BGNE |
1,215,307 13.200% |
254,380 (+26.47%) |
Filing History |